KwaZulu-Natal could soon see a major shift in the fight against HIV following the arrival of a groundbreaking prevention drug in South Africa. Health officials have confirmed that the first batch of lenacapavir — a long-acting injectable offering six months of protection — is now in the country, raising hopes for high-burden provinces like KZN.
With the province continuing to record some of the highest HIV infection rates in the country, experts believe this twice-yearly injection could be a game changer, especially for vulnerable groups such as young women, sex workers and men who have sex with men.
Local health workers say one of the biggest challenges in KZN has been adherence to daily prevention pills. Lenacapavir’s long-lasting protection could ease that burden significantly, particularly in rural areas where access to clinics is limited.
The Department of Health has described the drug as a critical step toward reducing new infections and meeting the goal of ending AIDS as a public health threat by 2030.
While rollout details are still to be finalised, communities across KZN are hopeful that the province will be prioritised. If implemented effectively, this innovation could mark a turning point in the region’s long-standing battle against HIV.
Email: motshwari@onenews.co.za
